Published in Neurology on December 14, 2004
Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study. Br J Psychiatry (2011) 1.58
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord (2008) 1.49
Hallucinations in Parkinson disease. Nat Rev Neurol (2009) 1.13
Pareidolias: complex visual illusions in dementia with Lewy bodies. Brain (2012) 1.11
Visuospatial functions in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry (2006) 1.05
Visual spatial cognition in neurodegenerative disease. Neurocase (2010) 1.03
Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. Br J Psychiatry (2012) 1.00
Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management. Front Neurol (2012) 0.98
Cataract and cognitive impairment: a review of the literature. Br J Ophthalmol (2010) 0.95
fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies. Neuroimage Clin (2014) 0.92
Psychiatric issues in cognitive impairment. Mov Disord (2014) 0.91
The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease. Behav Neurol (2016) 0.89
Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? J Neurol (2008) 0.88
Dementia with Lewy bodies. Neurol Clin (2007) 0.83
Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure. J Neural Transm (Vienna) (2010) 0.83
Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies. Am J Geriatr Psychiatry (2012) 0.82
Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice. Dis Model Mech (2012) 0.82
Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies. Arch Neurol (2008) 0.81
Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer's type and controls. J Neurol Neurosurg Psychiatry (2006) 0.81
UPDATE ON DEMENTIA WITH LEWY BODIES. Curr Transl Geriatr Exp Gerontol Rep (2013) 0.81
3D Shape Perception in Posterior Cortical Atrophy: A Visual Neuroscience Perspective. J Neurosci (2015) 0.80
White matter integrity and cognition in Parkinson's disease: a cross-sectional study. BMJ Open (2014) 0.80
The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease. J Alzheimers Dis (2014) 0.79
Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia. J Clin Exp Neuropsychol (2009) 0.79
Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition. Alzheimers Dement (2013) 0.78
Altered perceptual sensitivity to kinematic invariants in Parkinson's disease. PLoS One (2012) 0.78
Effects of transcranial direct current stimulation upon attention and visuoperceptual function in Lewy body dementia: a preliminary study. Int Psychogeriatr (2015) 0.78
Sentence processing in Lewy body spectrum disorder: the role of working memory. Brain Cogn (2012) 0.77
Visuo-cognitive skill deficits in Alzheimer's disease and Lewy body disease: A comparative analysis. Ann Indian Acad Neurol (2014) 0.76
Lewy body dementia and Parkinson's disease with dementia. J Neurol (2008) 0.76
Study of visuospatial skill in patients with dementia. Ann Indian Acad Neurol (2016) 0.76
Neurophysiological biomarkers for Lewy body dementias. Clin Neurophysiol (2015) 0.76
Impairment of script comprehension in Lewy body spectrum disorders. Brain Lang (2013) 0.76
Visual dysfunction in Parkinson's disease. Brain (2016) 0.75
Preclinical polymodal hallucinations for 13 years before dementia with Lewy bodies. Behav Neurol (2014) 0.75
Arguing against the proposed definition changes of PD. Mov Disord (2016) 0.75
Exercise for Individuals with Lewy Body Dementia: A Systematic Review. PLoS One (2016) 0.75
Oculo-Visual Dysfunction in Parkinson's Disease. J Parkinsons Dis (2015) 0.75
Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies. Transl Psychiatry (2016) 0.75
Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease. Hum Brain Mapp (2015) 0.75
Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson's disease. Eur J Med Res (2014) 0.75
Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors. Clin Interv Aging (2014) 0.75
Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations. Acta Neuropathol Commun (2016) 0.75
Parkinson's Disease and Cognitive Impairment. Parkinsons Dis (2016) 0.75
Motion discrimination in dementia with Lewy bodies and Alzheimer disease. Neurology (2015) 0.75
A protocol to examine vision and gait in Parkinson's disease: impact of cognition and response to visual cues. F1000Res (2015) 0.75
Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review. Brain Sci (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage (2003) 2.67
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Motion: the long and short of it. Spat Vis (1989) 2.27
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol (2010) 2.21
Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos (1999) 2.18
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Drugs for Alzheimer's disease. BMJ (2001) 1.92
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol (1999) 1.85
Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study. Eur J Neurol (2014) 1.85
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2006) 1.83
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.65
The motion aftereffect. Trends Cogn Sci (1998) 1.63
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry (2000) 1.61
Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology (2001) 1.59
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr (2001) 1.57
Age associated memory impairment. BMJ (1992) 1.54
A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology (2004) 1.48
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain (2001) 1.44
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage (2002) 1.44
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Time course of response to electroconvulsive therapy in elderly depressed subjects. Int J Geriatr Psychiatry (1997) 1.40
A periodically active pulsar giving insight into magnetospheric physics. Science (2006) 1.39
Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.36
Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology (2003) 1.35
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology (2001) 1.34
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology (2001) 1.32
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
Cognitive performance in hypertensive and normotensive older subjects. Hypertension (2000) 1.31
Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav (2002) 1.28
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry (2002) 1.28
Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology (2005) 1.28
Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology (2003) 1.28
Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord (2008) 1.27
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry (2006) 1.21
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20
MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology (2000) 1.19
Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord (2000) 1.18
Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology (1999) 1.16
Transient radio bursts from rotating neutron stars. Nature (2006) 1.15
White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol (2007) 1.14
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology (2000) 1.14
Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord (2011) 1.13
Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology (2003) 1.11
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord (1993) 1.11
The pattern and course of cognitive impairment in late-life depression. Psychol Med (2009) 1.11
A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Geriatr Cogn Disord (2002) 1.10
A case of parkinsonism associated with multiple sclerosis. Mov Disord (1996) 1.09
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype. J Neurol Neurosurg Psychiatry (2008) 1.08
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience (1995) 1.08
A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry (2006) 1.07
Depression with late onset is associated with right frontal lobe atrophy. Psychol Med (2003) 1.05
Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes. Int J Geriatr Psychiatry (1998) 1.05
Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage (2003) 1.05
A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord (2001) 1.05
The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2005) 1.05
A simultaneous shift in apparent direction: further evidence for a "distribution-shift" model of direction coding. Q J Exp Psychol (1980) 1.04
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease. Neurology (1994) 1.04
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol (2004) 1.03
A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol Med (2008) 1.03
Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study. Ann Neurol (1997) 1.02
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) (2000) 1.02
The movement aftereffect and a distribution-shift model for coding the direction of visual movement. Perception (1980) 1.02
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport (1994) 1.01
Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease. J Neuropsychiatry Clin Neurosci (1995) 1.01
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med (2009) 1.01
Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology (2004) 1.00